SCHEMBL3402941

SCHEMBL3402941

NC(=O)c1c2ccccc2nc2ccc(CC(=O)O)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.47
KDM4E B2RXH2 6/20 0.44
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
MAPT P10636 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PDE4B Q07343 2/20 0.42
SLC22A12 Q96S37 1/20 0.42
LMNA P02545 3/20 0.41
POLB P06746 2/20 0.41
GLA P06280 2/20 0.41
CYP2C9 P11712 1/20 0.41
PLA2G10 O15496 2/20 0.40
PLA2G2A P14555 1/20 0.40
GAA P10253 2/20 0.40
ABCC4 O15439 1/20 0.40
TSHR P16473 1/20 0.40
PTGS1 P23219 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9333487 0.88 LMNA (0.49) AKR1B1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3405725 0.85 HPGD (0.49) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL30148539 0.81 HSD17B10 (0.52) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL61597 0.81 HSD17B10 (0.52) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL3400668 0.79 KDM4E (0.47) AKR1B1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL1420724 0.76 NCOA1 (0.47) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4163106 0.75 KDM4E (0.53) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL9424806 0.74 CYP1A2 (0.50) AKR1B1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL3402945 0.74 TDP1 (0.51) AKR1B1KDM4EALDH1A1HPGDMAPT
SCHEMBL27497871 0.72 AKR1B1 (0.71) AKR1B1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100129800-A1 POLYMERS AND THEIR USE AS FLUORESCENT LABELS AYMAMI BOFARULL JUAN 2010-05-27 US disclosed
WO-2009007397-A1 NEW POLYMERS AND THEIR USE AS FLUORESCENT LABELS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-01-15 WO disclosed
EP-2014698-A1 Polymers and their use as fluorescent labels Crystax Pharmaceuticals S.L. (ES) 2009-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100129800-A1 POLYMERS AND THEIR USE AS FLUORESCENT LABELS CBR3, H1-0, H1-3 AKR1B1 262/4885KDM4E 3889/4885ALDH1A1 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.